No. | Symbol | Company | Analyst Recommendation / Rating Change | Target Price | Date | Chart |
---|---|---|---|---|---|---|
1 | AGNC | AGNC Investment | Rating: Buy | $10.25 | 02-20-2024 | View Chart |
2 | AVBP | ArriVent BioPharma | Rating: Buy | $30 | 02-20-2024 | View Chart |
3 | BKNG | Booking Holdings | Rating: Buy | $4380 | 02-20-2024 | View Chart |
4 | BTMD | biote Corp. | Rating: Buy | $9 | 02-20-2024 | View Chart |
5 | BTSG | BrightSpring Health Services | Rating: Hold | $11.50 | 02-20-2024 | View Chart |
6 | CGON | CG Oncology | Rating: Overweight | $55 | 02-20-2024 | View Chart |
7 | DYN | Dyne Therapeutics | Rating: Buy | $36 | 02-20-2024 | View Chart |
8 | ENGN | enGene Holdings | Rating: Outperform | $31 | 02-20-2024 | View Chart |
9 | IMVT | Immunovant Sciences | Rating: Overweight | $51 | 02-20-2024 | View Chart |
10 | MSDL | Morgan Stanley Direct Lending | Rating: Outperform | $22 | 02-20-2024 | View Chart |
11 | NCDL | Nuveen Churchill Direct Lending Corp. | Rating: Neutral | $18 | 02-20-2024 | View Chart |
No. | Symbol | Company | Analyst Recommendation / Rating Change | Target Price | Date | Chart |
---|---|---|---|---|---|---|
1 | DRVN | Driven Brands | Rating: Overweight | $19>>18 | 02-20-2024 | View Chart |
No. | Symbol | Company | Analyst Recommendation / Rating Change | Target Price | Date | Chart |
---|---|---|---|---|---|---|
1 | DKNG | DraftKings | Rating: Buy | $50>>54 | 02-20-2024 | View Chart |